Results 31 to 40 of about 207,765 (264)

The Pattern of Hematological Malignancies at Al-Gamhouria Teaching Hospital, Aden, Yemen, from 2008 to 2010

Turkish Journal of Hematology, 2012
OBJECTIVE: The aim of this study was to determine the pattern of hematological malignancies at Al-Gamhouria Teaching Hospital from 2008 to 2010. METHODS: Hematological malignancies diagnosed at Al-Gamhouria Teaching Hospital, Department of Hematology ...
Gamal Abdul Hamid
doaj   +1 more source

Classic Hodgkin lymphoma-nodular sclerosis – case report [PDF]

Romanian Medical Journal, 2023
Hodgkin's lymphoma is the third most common cancer in young people between 15 and 34 years of age, with a lower incidence in other age groups and slightly higher in males.
Mihaela Lebedenco , Nicoleta Berbec, Oana Stanca, Anca Roxana Lupu   +3 more
doaj   +1 more source

Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study [PDF]

, 2008
Summary Myelosuppression, particularly febrile neutropenia (FN), are serious dose-limiting toxicities that occur frequently during the first cycle of chemotherapy.
Impact of Neutropenia in Chemotherapy-European Study Group (INC-, Paridaens, R, Szucs, Thomas D., Matthias Schwenkglenks, Pettengell, R, Bosly, André, Schwenkglenks, Matthias, Jackisch, C, Jackisch, Christian, Thomas D. Szucs, Manuel Constenla, Constenla, Manuel, Szucs, T D, Schwenkglenks, M, André Bosly, Leonard, Robert, Paridaens, Robert, Christian Jackisch, Robert Leonard, Pettengell, Ruth, Ruth Pettengell, Robert Paridaens, Bosly, A, Impact of Neutropenia in Chemotherapy-European Study Group,, Szucs, TD, Leonard, R, Constenla, M   +26 more
core   +1 more source

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery [PDF]

, 2010
BACKGROUND: In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented.
Lyman, Gary H., Lyman, Gary H, Szucs Thomas D, Culakova Eva, Szucs, Thomas D., Thomas D Szucs, Pettengell, Ruth, Szucs, Thomas D, Eva Culakova, Lyman, GH, Culakova, Eva, Ruth Pettengell, Matthias Schwenkglenks, Pettengell, R, Schwenkglenks, Matthias, Szucs, TD, Gary H Lyman, Pettengell Ruth, Culakova, E, Schwenkglenks Matthias, Lyman Gary H, Lyman, G H, Szucs, T D, Schwenkglenks, M   +23 more
core   +1 more source

Additional file 1: of Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkinâ s lymphoma

, 2018
Supplemental materials. Results of additional analysis on delineation with a fixed relative threshold (MTVt41) and a fixed absolute threshold (MTV2.5) in comparison with the background-adapted semi-automated delineation presented in the main manuscript (MTVBG) [39]. (DOCX 3060 kb)
Rogasch, Julian, Hundsdoerfer, Patrick, Hofheinz, Frank, Wedel, Florian, Schatka, Imke, Amthauer, Holger, Furth, Christian   +6 more
openaire   +1 more source

Additional file 1: Table S1. of Clinical and prognostic analysis of 78 patients with human immuno-deficiency virus associated non-Hodgkinâ s lymphoma in Chinese population

, 2017
Regimens of chemotherapy. Table S2. Univariate analysis of the factors affecting CR in DLBCL and BL patients. (DOCX 14 kb)
Shen, Yang, Zhang, Renfang, Liu, Li, Shen, Yinzhong, Song, Wei, Qi, Tangkai, Tang, Yang, Wang, Zhenyan, Guan, Liqian, Lu, Hongzhou   +9 more
openaire   +1 more source

Nasal Maggot Infection in a Patient With Nasal Non-Hodgkin’s Lymphoma

Ear, Nose & Throat Journal, 2023
We describe a case of nasal non-Hodgkin’s lymphoma in a 79-year-old Chinese patient accompany with nasal myiasis. The first 2 biopsies in this case were false negative. Subsequently, nasal maggots developed in this patient.
Jing Ou Master of Medicine, Yan Huang Doctor of Medicine   +1 more
doaj   +1 more source

Anthropometric characteristics and non-Hodgkin’s lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Haematologica, 2008
Background The incidences of non-Hodgkin’s lymphoma and multiple myeloma are increasing steadily. It has been hypothesized that this may be due, in part, to the parallel rising prevalence of obesity.
Julie A. Britton, Aneire E. Khan, Sabine Rohrmann, Nikolaus Becker, Jakob Linseisen, Alexandra Nieters, Rudolf Kaaks, Anne Tjønneland, Jytte Halkjær, Marianne Tang Severinsen, Kim Overvad, Tobias Pischon, Heiner Boeing, Antonia Trichopoulou, Victoria Kalapothaki, Dimitrios Trichopoulos, Amalia Mattiello, Giovanna Tagliabue, Carlotta Sacerdote, Petra H.M. Peeters, H. Bas Bueno-de-Mesquita, Eva Ardanaz, Carmen Navarro, Paula Jakszyn, Jone M. Altzibar, Göran Hallmans, Beatrice Malmer, Göran Berglund, Jonas Manjer, Naomi Allen, Timothy Key, Sheila Bingham, Hervé Besson, Pietro Ferrari, Mazda Jenab, Paolo Boffetta, Paolo Vineis, Elio Riboli   +37 more
doaj   +1 more source

Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma [PDF]

, 2008
The effect of utilising granulocyte colony-stimulating factor (G-CSF) to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma (NHL) on long-term mortality patterns has not been formally evaluated.
Radford, JA, W D J Ryder, S Bhattacharya, Pettengell, R, Clamp, AR, Ryder, WD, R Pettengell, Bhattacharya, S, A R Clamp, J A Radford, Pettengell, Ruth, Bhattacharya, Soumo, Ryder, W David J, Clamp, Andrew R, Radford, John A   +14 more
core   +1 more source

Angiogenesis in Hodgkin’s lymphoma [PDF]

, 2018
Angiogenesis is a multistep process controlled by a number of stimulating and inhibiting factors. Aberrant angiogenesis is involved in cancer progression.
Rość, Danuta; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland, Boińska, Joanna; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland, Filipiak, Jan; Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland; Department of Chemotherapy, Oncology Centre-Prof. Franciszek Łukaszczyk Memorial Hospital, Romanowskiej 2, 85-796 Bydgoszcz, Poland   +2 more
core   +1 more source